SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-133196
Filing Date
2024-05-07
Accepted
2024-05-07 16:36:01
Documents
17
Period of Report
2024-05-07
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d815387d8k.htm   iXBRL 8-K 31358
2 EX-1.1 d815387dex11.htm EX-1.1 173562
3 EX-5.1 d815387dex51.htm EX-5.1 10162
4 EX-5.2 d815387dex52.htm EX-5.2 11077
8 GRAPHIC g815387g0506213415396.jpg GRAPHIC 2452
  Complete submission text file 0001193125-24-133196.txt   417634

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA mdgl-20240507.xsd EX-101.SCH 2871
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE mdgl-20240507_lab.xml EX-101.LAB 18757
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mdgl-20240507_pre.xml EX-101.PRE 11724
20 EXTRACTED XBRL INSTANCE DOCUMENT d815387d8k_htm.xml XML 3802
Mailing Address 200 BARR HARBOR DRIVE, SUITE 400 WEST CONSHOHOCKEN PA 19428
Business Address 200 BARR HARBOR DRIVE, SUITE 400 WEST CONSHOHOCKEN PA 19428 404-380-9263
MADRIGAL PHARMACEUTICALS, INC. (Filer) CIK: 0001157601 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33277 | Film No.: 24922619
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)